These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38238181)

  • 1. Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: a multicentre observational study.
    Fortini S; Costanzo E; Rellini E; Amore F; Mariotti SP; Varano M; Parravano M; Virgili G; Bandello F; Rizzo S; Turco S
    BMJ Open; 2024 Jan; 14(1):e075141. PubMed ID: 38238181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmologists perceived usefulness of Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) for evaluating the mental health of patients with chronic eye diseases.
    AlSwailem S; Fortini S; Ahmed A; Mariotti SP; Shahwan S; Khandekar R
    Eur J Ophthalmol; 2022 Jul; 32(4):1966-1970. PubMed ID: 34516321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?
    Polfer EM; Alici Y; Baser RE; Healey JH; Bartelstein MK
    Clin Orthop Relat Res; 2022 Nov; 480(11):2148-2160. PubMed ID: 35901433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the best cut-off points of PHQ-2 and GAD-2 for detecting depression and anxiety in Italian cardiovascular inpatients.
    Giuliani M; Gorini A; Barbieri S; Veglia F; Tremoli E
    Psychol Health; 2021 Sep; 36(9):1088-1101. PubMed ID: 33026888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of patient emotional health status: impact on clinical care in glaucoma and retinal services.
    Naufal F; Gajwani P; Medina R; Dutson M; Mariotti SP; West SK
    BMJ Open Ophthalmol; 2021; 6(1):e000640. PubMed ID: 33981855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
    Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
    J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factorial invariance of the Patient Health Questionnaire and Generalized Anxiety Disorder Questionnaire.
    Ryan TA; Bailey A; Fearon P; King J
    Br J Clin Psychol; 2013 Nov; 52(4):438-49. PubMed ID: 24117915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
    Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
    J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and Behavior of Primary Care Physicians Regarding Utilization of Standardized Tools in Screening and Assessment of Anxiety, Depression, and Mood Disorders at a Large Integrated Health System.
    Waheed A; Afridi AK; Rana M; Arif M; Barrera T; Patel F; Khan MN; Azhar E
    J Prim Care Community Health; 2024; 15():21501319231224711. PubMed ID: 38327064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.
    Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the patient health questionnaire-9 and the generalized anxiety disorder-7 in Lithuanian student sample.
    Pranckeviciene A; Saudargiene A; Gecaite-Stonciene J; Liaugaudaite V; Griskova-Bulanova I; Simkute D; Naginiene R; Dainauskas LL; Ceidaite G; Burkauskas J
    PLoS One; 2022; 17(1):e0263027. PubMed ID: 35085349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and depression in patients wearing prosthetic eyes.
    Heindl LM; Trester M; Guo Y; Zwiener F; Sadat N; Pine NS; Pine KR; Traweger A; Rokohl AC
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):495-503. PubMed ID: 32870372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking the GAD-7 and PHQ-9 to the TBI-QOL Anxiety and Depression Item Banks.
    Boulton AJ; Tyner CE; Choi SW; Sander AM; Heinemann AW; Bushnik T; Chiaravalloti N; Sherer M; Kisala PA; Tulsky DS
    J Head Trauma Rehabil; 2019; 34(5):353-363. PubMed ID: 31498233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
    Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the relationship between generalised anxiety/depression scales and asthma-specific quality of life/control questionnaires in a specialist asthma clinic.
    Robinson R; Barber K; Jones G; Blakey J; Burhan H
    J Asthma; 2021 Jul; 58(7):912-920. PubMed ID: 32186425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
    Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
    Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
    Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
    J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder.
    Huang XJ; Ma HY; Wang XM; Zhong J; Sheng DF; Xu MZ
    J Affect Disord; 2022 Aug; 311():327-335. PubMed ID: 35598748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, anxiety and related factors among Syrian breast cancer patients: a cross-sectional study.
    Soqia J; Al-Shafie M; Agha LY; Alameer MB; Alhomsi D; Saadoun R; Saifo M
    BMC Psychiatry; 2022 Dec; 22(1):796. PubMed ID: 36528568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain Injury.
    Teymoori A; Real R; Gorbunova A; Haghish EF; Andelic N; Wilson L; Asendorf T; Menon D; von Steinbüchel N
    J Affect Disord; 2020 Feb; 262():278-285. PubMed ID: 31732280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.